ARTICLE | Distillery Therapeutics
Therapeutics: Major histocompatibility complex class II (MHCII)
May 21, 2015 7:00 AM UTC
Mouse studies suggest up-regulating MHCII-expressing group 3 innate lymphoid cells (ILC3s) in the intestines could help treat IBD. MHCII expression on ILC3s was lower in the intestinal tissue of pedia...